Michael Occidental

Dr. Michael Occidental

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
ARAbigail Russ
Abigail Russ
JMJoana Mack
Joana Mack
AGAudrey Green-Murphy
Audrey Green-Murphy
MOMichael Occidental
Michael Occidental
AMAmir Mian
Amir Mian
Griscelli syndrome type 2 (GS2) is an autosomal recessive condition associated with the development of hemophagocytic lymphohistiocytosis. GS2 is caused by a gene mutation involving RAB27A, which affects a melanosome anchoring complex in melanocytes and releases cytolytic granules from T cells and natural killer cells. GS2 is known to have immunologic compromise and oculocutaneous albinism. We present the case of 2 sisters who had vastly different phenotypic presentations despite having the same genetic frameshift mutation in the RAB27A gene. Patient 1 presented with seizures and neurological compromise, whereas patient 2 presented with pancytopenia and diarrhea. Both patients developed hemophagocytic lymphohistiocytosis.

30 April 2020 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
MOMichael Occidental
Michael Occidental
GSGuomiao Shen
Guomiao Shen
XFXiaojun Feng
Xiaojun Feng
KZKelsey Zhu
Kelsey Zhu
KKKevin Kelly
Kevin Kelly
George JourGeorge Jour
George Jour

8 September 2020 in Journal of Cutaneous Pathology
Verified
Journal Article
Open access
PDF file
MOMichael Occidental
Michael Occidental
AFAbdallah Flaifel
Abdallah Flaifel
LLLawrence Hsu Lin
Lawrence Hsu Lin
MGMelissa Guzzetta
Melissa Guzzetta
KTKristen Thomas
Kristen Thomas
George JourGeorge Jour
George Jour
COVID‐19, an infectious disease caused by the novel coronavirus, was initially identified in Wuhan, China, in December 2019. By March 2020, it was declared a pandemic by the World Health Organization. Although most findings have been reported in the lungs, primarily due to catastrophic respiratory decline, other organs, including the skin, are affected. Recent reports have been published describing the clinical spectrum of COVID‐19‐related lesions. In addition, recent case series have described a subset of these lesions having underlying thrombotic microangiopathy with increased complement activation characterized by increased C4d deposition within the blood vessel walls. Herein, we describe a series of COVID‐19‐related cutaneous manifestations found at autopsy examination and their underlying histopathologic findings. Although the clinical manifestations seen in these lesions vary widely, the underlying etiology of thrombotic microangiopathy remains consistent and reproducible.

19 November 2024 in Clinical Cancer Research
Verified
Journal Article
Closed access
NCNicolas Coudray
Nicolas Coudray
MOMichael Occidental
Michael Occidental
JMJose G. Mantilla
Jose G. Mantilla
AQAdalberto Claudio Quiros
Adalberto Claudio Quiros
KYKe Yuan
Ke Yuan
George JourGeorge Jour
George Jour
Purpose: Necrosis quantification in the neoadjuvant setting using pathology slide review is the most important validated prognostic marker in conventional osteosarcoma. Herein, we explored three deep-learning strategies on histology samples to predict outcome for osteosarcoma in the neoadjuvant setting. Experimental Design: Our study relies on a training cohort from New York University (NYU; New York, NY) and an external cohort from Charles University (Prague, Czechia). We trained and validated the performance of a supervised approach that integrates neural network predictions of necrosis/tumor content and compared predicted overall survival (OS) using Kaplan–Meier curves. Furthermore, we explored morphology-based supervised and self-supervised approaches to determine whether intrinsic histomorphologic features could serve as a potential marker for OS in the neoadjuvant setting. Results: Excellent correlation between the trained network and pathologists was obtained for the quantification of necrosis content (R2 = 0.899; r = 0.949; P < 0.0001). OS prediction cutoffs were consistent between pathologists and the neural network (22% and 30% of necrosis, respectively). The morphology-based supervised approach predicted OS; P = 0.0028, HR = 2.43 (1.10–5.38). The self-supervised approach corroborated the findings with clusters enriched in necrosis, fibroblastic stroma, and osteoblastic morphology associating with better OS [log-2 hazard ratio (lg2 HR); −2.366; −1.164; −1.175; 95% confidence interval, (−2.996 to −0.514)]. Viable/partially viable tumor and fat necrosis were associated with worse OS [lg2 HR; 1.287; 0.822; 0.828; 95% confidence interval, (0.38–1.974)]. Conclusions: Neural networks can be used to automatically estimate the necrosis to tumor ratio, a quantitative metric predictive of survival. Furthermore, we identified alternate histomorphologic biomarkers specific to the necrotic and tumor regions, which could serve as predictors.

25 October 2025 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ABAnna L. Brinks
Anna L. Brinks
CNCarli D. Needle
Carli D. Needle
OPOlivia D. Perez
Olivia D. Perez
JSJerry Shapiro
Jerry Shapiro
KLKristen LoSicco
Kristen LoSicco
LPLynn Petukhova
Lynn Petukhova

1 July 2015 in Toxicon
Verified
Journal Article
Closed access
RKRandall A. Kopper
Randall A. Kopper
GHGeorge R. Harper
George R. Harper
MOMichael Occidental
Michael Occidental
VGVlad Gamalie
Vlad Gamalie
PSPles Spradley
Ples Spradley